本页面由Tiger Trade Technology Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

440.00
+2.210.50%
成交量:31.19万
成交额:1.37亿
市值:100.94亿
市盈率:-34.24
高:452.30
开:437.92
低:431.14
收:437.79
52周最高:615.00
52周最低:265.00
股本:2,294.00万
流通股本:1,100.01万
量比:0.53
换手率:2.84%
股息:- -
股息率:- -
每股收益(TTM):-12.8501
每股收益(LYR):-12.8501
净资产收益率:-42.49%
总资产收益率:-16.30%
市净率:16.75
市盈率(LYR):-34.24

数据加载中...

2026/02/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/19

重要事件披露

Form 8-K - Current report
2026/01/30

重要事件披露

Form 8-K - Current report
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]